calr mutation analysis, myeloproliferative neoplasm (mpn)
Published 10 years ago • 6.5K plays • Length 5:25Download video MP4
Download video MP3
Similar videos
-
20:44
myeloproliferative neoplasm [hot topic]
-
26:23
myeloproliferative neoplasms in 2014: morphology, molecular genetics, and test utilization
-
3:05
why is calr an ideal immunotherapeutic target for mpns?
-
1:46
the role of calr mutations in the initiation and progression of mpns
-
4:31
driver mutations in mpns and their impact on prognosis: jak2, mpl, and calr
-
23:17
mutations in myelofibrosis: which to test for, when and why
-
1:18
immunotherapeutic approaches in calr-mutated mpns
-
2:17
targeting calr with immunotherapy in mpns
-
18:46
ann mullally, md - calreticulin mutations in mpn
-
0:58
the potential of car-t therapy targeting mutant calr in myelofibrosis & essential thrombocythemia
-
1:24
the promise of mutant calr antibodies for the treatment of mpns
-
2:00
expression of cd47 and calr in mpns
-
12:42
essential thrombocythemia etiology. calr (calreticulin) mpl jak2 mutation. molecular pathogenesis
-
15:55
familial mutation targeted testing (fmtt)
-
2:21
using engineered calr-mutant human hscs to improve our understanding of mpns
-
1:58
the value of novel jak2 and calr-targeted therapies in mpns
-
17:10
optimal test utilization for bone marrow staging evaluations
-
1:04:47
myeloproliferative neoplasms mpns awareness